NEL-like molecule 1 (NELL1) is a potent osteogenic factor associated with craniosynostosis. Adenoviruses, the most commonly used viral vectors for gene therapy, have several disadvantages that may restrict osteogenesis. Previous studies have shown that lentiviruses can serve as ideal vectors for gene therapy for bone regeneration. In this study, two lentiviral vectors (LvNELL1 and LvBMP2) that encode human NELL1 and bone morphogenetic protein-2 (BMP2), respectively, were constructed. The effect of LvNELL1 infection on the proliferation, osteogenesis, and adipogenesis of human adipose-derived stem cells (hADSCs) in vitro was assessed and compared with that of LvBMP2. The results showed that hADSCs infected with LvNELL1 could efficiently and stably overexpress the target genes. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay results demonstrated that LvBMP2, but not LvNELL1, enhanced the proliferation of hADSCs. Assessment of alkaline phosphatase activity and cellular mineralization indicated that LvNELL1 infection promoted the osteogenic differentiation of hADSCs, and the effect was comparable with that of LvBMP2. Real-time polymerase chain reaction (PCR) revealed that LvNELL1 infection upregulated OSX expression but not RUNX2 expression in hADSCs. In addition, adipogenic markers (lipid droplets, peroxisome proliferator-activating receptor g, and lipoprotein lipase) analysis showed that LvNELL1 could dramatically inhibit the adipogenic differentiation of hADSCs, but LvBMP2 had no such effect. Taken together, these findings suggested that lentiviral-mediated NELL1 gene transfer in hADSCs may be a novel and promising approach to achieve effective and precise bone regeneration.
Introduction
Adipose-derived stem cells (ADSCs) are a population of multipotent mesenchymal stem cells (MSCs) that can differentiate toward the osteochondral lineage under appropriate conditions [1] . As they can be easily obtained in large quantities with minimal donor-site morbidity, ADSCs are considered as a better source of autologous stem cells than bone marrow stromal cells (BMSCs) for bone tissue engineering [2] .
Bone morphogenetic protein-2 (BMP2) is a wellestablished osteogenic factor that can induce bone formation. Besides the osteoinductive effect, BMP2 has multiple other biological activities [3] and can induce ectopic osteogenesis [4] . Thus, the application of large doses of BMP2 may have potential adverse effects [5] . NEL-like molecule 1 (NELL1) is a secreted protein associated with craniosynostosis [6] . Transgenic mice overexpressing NELL1 exhibit a phenotype similar to human craniosynostosis, showing calvarial overgrowth [7] . NELL1-deficient mice exhibit developmental defects not only in the calvaria but also in long bones [8] . These findings suggested that NELL1 plays an important role in the bone development [9] . In recent years, studies have revealed that NELL1 is a potent osteogenic factor, as it can specifically promote osteogenic differentiation of osteoblasts and MSCs and facilitate bone regeneration in several animal models [10] [11] [12] [13] . Differing from BMP2, NELL1 acts downstream of, and is regulated by, Runt-related transcription factor 2 (RUNX2), a key regulator of osteogenesis. Thus, it seems that the osteogenic effect of NELL1 is specific [10, [14] [15] [16] . More importantly, the biological effect of NELL1 is mainly limited to the skeletal system [7] [8] [9] , and NELL1 cannot independently induce osteogenesis in the muscle [16] . Thus, NELL1 does not induce undesired osteogenesis at sites outside of the injured region.
Several studies have proved that adenovirus vectors encoding NELL1 (AdNELL1) can induce bone formation in animal models [11] [12] [13] . However, adenoviral-mediated gene expression cannot be maintained for a very long period of time, and adenovirus vectors may induce an immune response in the host [17 -19] . In contrast, lentiviruses can integrate into the genome of host cells and allow stable expression of target genes over the long term [20, 21] . Given that the bone regeneration is a long-term process, lentiviral vectors may be a more useful tool for the repair of various bone defects, especially large bone defects or those within a compromised biological environment [22] . Miyazaki et al. [23] have found that lentiviralmediated BMP2 gene transfer could achieve more abundant bone formation in a rat spinal fusion model compared with adenoviral-mediated gene transfer. The duration of gene expression is also a factor related to the quality of bone formed during gene therapy. Experiments have shown that, compared with adenoviral-mediated gene transfer, lentiviral-mediated BMP2 gene transfer in rats with femoral defects could achieve formation of bone with higher biomechanical strength [24] . Thus, prolonged gene expression mediated by lentiviruses may be more beneficial for gene therapy to induce bone regeneration.
Osteoblasts and adipocytes are derived from a common precursor, MSCs. Theoretically, there is an inverse relationship between osteogenesis and adipogenesis of MSCs to promote the differentiation toward one lineage may inevitably inhibit differentiation toward the other [25 -27] . The reciprocal regulation between adipogenesis and osteogenesis of MSCs may provide a new prospective for the bone regenerative therapy. Although BMP2 has potent osteoinductive activity, it also induces adipogenic differentiation of MSCs [28] [29] [30] . In contrast, NELL1 can effectively inhibit adipogenic differentiation of MSCs [31] , which suggests that the effect of NELL1 on the commitment of MSCs to differentiate into osteoblasts or adipocytes is different from that of BMP2.
On the basis of the above evidence, we hypothesized that the combination of potent and specific osteogenic factors, optimal adult stem cells, and vectors allowing prolonged gene expression might be more beneficial for bone tissue engineering in clinical practice. hADSCs overexpressing NELL1 delivered by lentiviral vectors might serve as a novel and promising strategy when ex vitro gene therapy was used for bone repair and regeneration. The purpose of this study was to investigate the feasibility of infection of hADSCs with lentiviruses encoding NELL1 (LvNELL1) and to compare the effect of lentiviral-mediated expression of NELL1 or BMP2 on the proliferation, osteogenesis, and adipogenesis of hADSCs in vitro. The results obtained from this study will lay the foundation for developing an exciting strategy for gene therapy to effectively and accurately stimulate bone regeneration.
Materials and Methods

Construction of lentiviral vectors
Enhanced green fluorescent protein (EGFP) is a fluorescence maker that can be used to dynamically monitor infection efficiency and the expression of target genes in living cells [32] . In this study, lentiviral vectors containing an internal ribosome entry sequence (IRES) [24] were constructed, which could express both target genes and EGFP. In brief, the sequence of human NELL1 gene was retrieved from GenBank (NM 006157.3), and oligonucleotides were designed and synthesized based on this sequence. Restriction enzyme sites (BamHI and NheI) were then added to each end of the oligonucleotides, respectively. Polymerase chain reaction (PCR) was performed to connect the synthesized oligonucleotides into a complete sequence, which was then introduced to pMD-18T (TaKaRa Bio, Shiga, Japan). The resulting recombinant vector was transformed into competent Escherichia coli DH5a cells. Overlap PCR was employed to repair the mutation site in the NELL1 gene. Following digestion with BamHI/NheI (Fermentas, Glen Burnie, USA), the fragment was ligated into plenti6.3-MSC-IRES2-EGFP (Invitrogen, Carlsbad, USA), and the resulting vectors were transformed into competent E. coli Stb13 cells to construct plenti6.3-NELL-IRES-EGFP (LvNELL1) driven by the cytomegalovirus promoter. Using the same procedure, a lentiviral vector carrying the human BMP2 gene (Lenti-BMP2-IRES-EGFP; LvBMP2) was also constructed. The Lenti-IRES-EGFP vector (LvEGFP) was used as a negative control.
Lentiviral packaging
The lentiviral vector (LvNELL1, LvBMP2, or LvEGFP) was added to Opti-MEM (Invitrogen), followed by sequential addition of Packing Mix (Invitrogen) and Lipofectamine (Invitrogen). The resulting mixture was added to 293FT cells, which were maintained in Opti-MEM and incubated in 5% CO 2 at 378C for 6 h. After refreshing the culture medium with complete medium [Dulbecco's modified Eagle's medium (DMEM) þ 10% fetal bovine serum; Invitrogen], the cells were incubated for 48 h and the supernatant was collected, followed by centrifugation at 1150 g for 10 min and filtering through a 0.45-mm filter. The virus solution was then centrifuged at 50,000 g for 2 h and the supernatant was removed. The virus was resuspended in DMEM and stored at 2808C for further use.
Cell culture and lentiviral infection hADSCs, purchased from Cyagen Biosciences (Guangzhou, China), were isolated from the adult adipose tissue and maintained in general medium (Cyagen Biosciences). Cells at passages 4-6 were used in the following experiments.
When cell confluence reached 80%, the medium was removed and the cells were washed with phosphate buffered saline (PBS). Infection of cells with LvNELL1, LvBMP2, or LvEGFP at a multiplicity of infection (MOI) of 150 viral particles/cell was then implemented in the presence of 8 mg/ ml of polybrene (Invitrogen). After cells were incubated in 5% CO 2 at 378C for 16 h, the supernatant was removed, and the cells were washed with PBS and then maintained in complete medium. The proportion of green fluorescencepositive cells was calculated by counting cells in five highpower fields under a microscope (IX71; Olympus, Tokyo, Japan) to evaluate infection efficiency.
Quantitative real-time PCR Total RNA was extracted with Trizol (Invitrogen), and the RNA concentration and purity were determined with a BioPhotometer plus UV spectrophotometer (Eppendorf, Hamburg, Germany). Quantitative real-time PCR (qPCR) was conducted using SYBR Green Real-time PCR Master Mix (TOYOBO, Osaka, Japan) to determine the expression of the target genes and marker genes in osteogenesis and adipogenesis using an ABI Prism 7500 real-time PCR system (Applied Biosystems, Foster City, USA). The primer sequences are shown in Table 1 . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as an internal reference. Analysis was based on calculating the relative expression level of the gene of interest compared with GAPDH, which was then normalized to the expression level induced by the LvEGFP control on Day 0 after infection [10] . Reactions were performed in triplicate.
Western blot analysis Cells were lysed using a cell lysis buffer (Beyotime, Shanghai, China). Proteins were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis for fractionation and then transferred onto a polyvinylidene fluoride membrane (Millipore, Billerica, USA). The membrane was then incubated with mouse anti-human NELL1 (Sigma-Aldrich, St Louis, USA) antibody or rabbit antihuman BMP2 antibody (Peprotech, Rocky Hill, USA), followed by incubation with a goat anti-mouse or goat anti-rabbit secondary antibody (Santa Cruz Biotechnology, Santa Cruz, USA). Visualization was performed with enhanced chemiluminescence detection reagents (Thermo Fisher Scientific, Rockford, USA). GAPDH served as an internal reference. A FluorChem HD2 gel image system (ProteinSimple, Santa Clara, USA) was employed to determine the expression of target proteins.
Effect of gene transfer on in vitro proliferation of hADSCs
To assess the effect of lentiviral-mediated NELL1 and BMP2 gene transfer on the proliferation of hADSCs in vitro, infected cells were seeded into a 96-well plate at a density of 2000 cells/well. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) in PBS ( pH 7.4) was added to each well (5 mg/ml) and allowed to incubate at 378C for 4 h. The supernatant was removed and 100 ml of dimethyl sulfoxide was added, followed by shaking for 10 min to dissolve the crystals [33] . The optical density (OD) of each well was determined at 490 nm with a microplate reader. Assays were performed in quadruplicate at each time point.
Effect of lentiviral-mediated gene transfer on in vitro osteogenesis of hADSCs Lentivirus-infected hADSCs were maintained in general medium for 24 h and then cultured in osteogenic differentiation medium (Cyagen Biosciences). On Days 7 and 14 after induction, alkaline phosphatase (ALP) activity was measured using a commercial kit (Jiancheng, Nanjing, China) following the manufacturer's instructions. In brief, cells were digested with trypsin and the cell suspension was mixed with matrix solution and allowed to incubate in a water bath at 378C for 15 min. The mixture was then mixed with visualization solution to measure OD at 490 nm. OD values were transformed into King units per 100 ml according to the OD 490 of the phenol standard and normalized to cell protein contents. Alizarin red staining was performed to detect cellular mineralization on Day 14 after induction. 
In brief, cells were fixed in 10% neutral formaldehyde for 30 min, washed with PBS, and stained with 0.5% alizarin red for 10 min. The cell morphology was observed under an inverted microscope and representative images were captured. Alizarin red was then eluted with 10% cetylpyridinium chloride as previously described [34] . The OD was measured at 490 nm and normalized to cell protein contents. Assays were performed in triplicate.
Effect of lentiviral-mediated gene transfer on in vitro adipogenesis of hADSCs Lentivirus-infected hADSCs were maintained in general medium for 24 h and then cultured in adipogenic differentiation medium (Cyagen Biosciences). Fourteen days after adipogenic induction, oil red O staining was performed to detect adipogenesis. In brief, the supernatant was removed and the cells were washed with PBS. The cells were then fixed in 10% formaldehyde at room temperature for 30 min, mixed with oil red O solution (0.5% oil red O staining solution : distilled water ¼ 3 : 2), and allowed to incubate for 30 min. The cell morphology was observed under a microscope and representative images were captured. Quantification of oil red O was performed as previously described [31] . Isopropanol was used to elute oil red O, and the OD was determined at 490 and normalized to cell protein contents. Assays were performed in triplicate.
Statistical analysis
Statistical analysis was performed using SPSS version 15.0 (SPSS, Chicago, USA). Numerical data were expressed as mean + standard deviation. Comparisons were performed with analysis of variance with post hoc comparison adjusted using the Bonferroni method. P , 0.05 was considered statistically significant.
Results
Lentiviral infection of hADSCs
In this study, lentiviral vectors encoding NELL1 or BMP2 were constructed and the feasibility of using these vectors to infect hADSCs was determined. As expected, when hADSCs were infected with LvNELL1, LvBMP2, or LvEGFP at an MOI of 150, the proportion of EGFP-positive cells was over 80% in all the three groups, with no excessive cellular death (Fig. 1) . Fluorescence images of LvNELL1-and LvBMP2-infected hADSCs revealed successful expression of NELL1 and BMP2. Moreover, overexpression of NELL1 and BMP2 at mRNA and protein levels was confirmed by qPCR and western blot on Day 7 after lentivirial infection [ Fig. 2(A-C) ]. These findings indicated that the recombinant lentiviruses encoding both EGFP and NELL1 or BMP2 could efficiently infect hADSCs and mediate the expression of target genes. In addition, fluorescence images of LvNELL1-infected hADSCs demonstrated the expression of NELL1 over a period of 8 weeks [ Fig. 2(D) ]. Prolonged expression of NELL1 protein was also confirmed by western blot at week 8 after infection [ Fig. 2(E) ]. These data suggest that LvNELL1-infected hADSCs are able to express NELL1 protein over a long period of time.
Effect of lentiviral-mediated gene transfer on cell proliferation A previous study has shown that NELL1 could significantly inhibit the proliferation of goat BMSCs [11] . In this study, MTT assay showed that, from the second day after infection, the proliferation of LvBMP2-infected hADSCs was significantly higher than that of LvEGFP-infected hADSCs except on the seventh day after infection (all P , 0.05), whereas there was no significant difference in cell proliferation between the LvNELL1 and LvEGFP groups at all time points (all P . 0.05; Fig. 3 ). Collectively, these data suggest that NELL1 appears to act on the differentiation, rather than the proliferation, of hADSCs.
Effect of lentiviral-mediated gene transfer on osteogenesis of hADSCs
Although recombinant NELL1 proteins have previously been shown to promote the osteogenesis of osteoblasts and MSCs, it is unknown whether NELL1 delivered by lentiviral vectors could enhance the osteogenesis of hADSCs. We therefore analyzed ALP activity and cellular mineralization in hADSCs following lentiviral-mediated NELL1 transfer. The results showed that on Days 7 and 14 after infection, ALP activity increased significantly both in the LvNELL1 and LvBMP2 groups compared with that in the LvEGFP group (P , 0.05), but no significant difference was observed between the LvBMP2 and LvNELL1 groups [P . 0.05; Fig. 4(A) ]. Alizarin red staining showed that by visual observation, the number of calcified nodules in the LvNELL1 and LvBMP2 groups on Day 14 after infection was markedly greater than that in the LvEGFP group [ Fig. 4(B) ]. Further quantitative analysis confirmed that mineralization in the LvNELL1 and LvBMP2 groups was more evident than that in the LvEGFP group (P , 0.01 for both), but there was no significant difference between the LvNELL1 and LvBMP2 groups [P . 0.05; Fig. 4(C) ]. Taken together, theses results indicate that hADSCs infected with LvBMP2 and those infected with LvNELL1 showed comparable osteogenesis in vitro.
We then investigated the effect of LvNELL1 and LvBMP2 infection on the expression of RUNX2 and Osterix (OSX) genes in hADSCs by qPCR on the seventh day after infection. RUNX2 is believed to be a master regulatory gene controlling osteoblast formation and function [35] , whereas OSX is a transcription factor that is located downstream of, and regulated by, RUNX2, and plays an important role in the late stage of osteogenic differentiation [36] . On the seventh day after gene transfer, RUNX2 expression was significantly increased in the LvBMP2 group (12.9 folds) compared with the LvEGFP group (5.6 folds) (P , 0.001), but no significant difference was detected between the LvNELL1 (5.5 folds) and LvEGFP groups [P . 0.05; Fig. 4(D) ]. Compared with LvEGFP, LvBMP2 significantly induced OSX expression on the seventh day after infection (11.6 vs. 3.2 folds, P , 0.001). OSX expression was significantly lower in the LvNELL1 group (8 folds) than that in the LvBMP2 group (P , 0.05), but was significantly higher in the LvNELL1 group than in the LvEGFP group [P , 0.01; Fig. 4(E) ]. Collectively, these results suggest that NELL1 and BMP2 induce osteogenic differentiation of hADSCs perhaps via different mechanisms at the transcriptional level.
Effect of lentiviral-mediated gene transfer on adipogenesis of hADSCs
Previous studies have demonstrated that NELL1 and BMP2 exert different regulatory effects on the balance between osteogenesis and adipogenesis of MSCs [28] [29] [30] [31] . We therefore compared the effect of LvNELL1 and LvBMP2 infection on the adipogenesis of hADSCs. Oil red O staining showed that the numbers of lipid droplets in the LvNELL1 group were lower than that in the LvEGFP group, but no marked difference was found between the LvEGFP and LvBMP2 groups [ Fig. 5(A) ]. Consistent with this finding, quantitative analysis also showed that the number of lipid droplets in the LvNELL1 group was significantly lower than that in the LvEGFP group (P , 0.001), whereas no significant difference was observed between the LvEGFP and LvBMP2 groups [P . 0.05; Fig. 5(B) ]. In addition, qPCR results indicated that the expression of peroxisome proliferator-activating receptor g (PPARg) and lipoprotein lipase (LPL) in the LvNELL1 group on Day 10 after gene transfer was significantly lower as compared with that in the LvEGFP group (P , 0.001). However, in the LvBMP2 group, PPARg expression was significantly higher than that in the LvEGFP group (P , 0.05), and no difference was found between those two groups for LPL expression [P . 0.05; Fig. 5(C,D) ]. These findings indicate that, at the transcriptional level, NELL1 could significantly inhibit PPARg expression, whereas BMP2 could upregulate PPARg expression during the adipogenesis of hADSCs. Taken together, these results demonstrate that LvNELL1 infection could inhibit adipogenesis of hADSCs in vitro. Although the stimulatory effect of LvBMP2 on the adipogenesis of hADSCs was not observed, lentivirus-mediated BMP2 gene transfer had no inhibitory effect on the adipogenesis of hADSCs.
Discussion
Ex vivo gene therapy has been regarded as a promising strategy for resolving the limitations of local administration of recombinant proteins [37] . NELL1 is a secreted protein which can stimulate bone formation not only through an autocrine mechanism but also through a paracrine mechanism during ex vivo gene therapy. Although adenoviral-mediated NELL1 gene therapy has been demonstrated to be effective in promoting bone regeneration, these experiments were performed mainly in small animal models [13] [14] [15] . Since adenoviral vectors predominantly persist as episomal DNA molecules in the host cell, the target genes cannot be expressed over the long term [17] [18] [19] . Thus, in the repair of bone defects in large animals or humans via adenovirus-mediated gene transfer, NELL1 cannot be persistently delivered to induce sufficient osteogenesis. In contrast, lentiviruses can integrate into the genome of host cells, and lentivirus-infected cells can stably express the target genes for a long period of time [13, 14] . Feeley et al. [22] introduced lentivirus-infected rat bone marrow cells into severe combined immune deficency (SCID) mice and found that BMP2 could be expressed in vivo for more than 3 months, whereas adenoviral expression of BMP2 lasted only 21 days. Consistent with this finding, an earlier study [10] has also demonstrated that infection of MC3T3 cells with an adenoviral vector expressing NELL1 led to a peak expression of NELL1 on the third day after infection, and NELL1 expression began to decline sharply on the sixth day after infection [10] . In this study, the prolonged expression of the reporter gene suggested that lentivirus-mediated NELL1 gene transfer could lead to long-term expression of NELL1, which is different from adenovirus-mediated gene transfer. Evidence shows that lentiviral-mediated long-term expression of target genes is more beneficial during gene therapy for bone regeneration.
In vivo experiments have indicated that compared with adenoviruses, lentivirus-mediated BMP2 gene therapy with BMSCs can induce more abundant bone formation [23] and that the regenerated bone has higher biomechanical strength [24] .
In contrast, prolonged delivery of osteogenic factors (i.e. BMP2) may lead to undesired side effects. As mentioned above, the osteoinductive effect of NELL1 appears to be more specific than BMP2.In addition, the development of tetracycline-controlled gene expression system may contribute to resolving this problem [38] . The safety of viral vectors is also a concern in gene therapy. For lentiviral vectors, a series of modifications [such as introduction of the four-plasmid packaging system, elimination of the longterminal repeat, removal of accessory genes (vip, vpr, vpu, and nef ), and property of self-inactivation] have improved their biological safety [39, 40] . Our future study will investigate the feasibility of LvNELL1 gene therapy for bone regeneration in animal models and compare the volume and quality of newly generated bone and the safety of this technique relative to AdNELL1 infection.
A previous study has proved that the in vitro osteogenic effect of AdNELL1 on goat BMSCs is comparable with that of AdBMP2 [11] . Consistent with this finding, detection of ALP activity and cellular mineralization levels in our study demonstrated that the osteogenic effect of LvNELL1 on hADSCs was comparable with that of LvBMP2. This result suggests that lentiviral-mediated NELL1 gene transfer into hADSCs may be a promising strategy for clinical gene therapy. However, the mechanism underlying the osteogenic effect of NELL1 is still unclear [9] . BMP2 exerts its osteogenic effect partially by upregulating RUNX2 expression [41] . In addition, BMP2 can upregulate OSX expression via RUNX2-dependent and RUNX2-independent pathways [36, 42] . It is known that there are three RUNX2-spicific binding sites (OSE-2) in the NELL1 promoter region, and NELL1 is located downstream of, and directly regulated by, RUNX2 [14, 15] . In this study, detection of RUNX2 expression confirmed that BMP2 and NELL1 acted at different hierarchical levels of the RUNX2 signaling pathway in osteogenesis, which may be attributed to different specificity of the osteogenic effects between BMP2 and NELL1 [9] . A previous study showed that AdNELL1 could significantly downregulate OSX expression during the osteogenesis of MC3T3-E1 cells [10] . In contrast, our findings revealed that LvNELL1 could significantly upregulate OSX expression in hADSCs. This discrepancy may be caused by different cell types or vectors used. In contrast, a recent study showed that NELL1 might be a downstream target of OSX. In silico analysis demonstrated that a cluster of potential Sp1 sites are located in the immediate vicinity of the transcriptional start site of the NELL1 gene. OSX could specifically bind to these Sp1 sites and inhibit NELL1 expression at the transcriptional level by affecting the binding of RNA polymerase II to the NELL1 promoter [43] . Thus, the upregulation of OSX by NELL1 observed in this study might be attributed to a transcription-based negative feedback loop between OSX and NELL1. This mechanism is similar to the negative feedback regulation of BMP2 signaling by Smad6 [44] .
In vitro studies have proved that BMP2 can promote the differentiation of C3H10T1/2 cells into adipocytes [28] [29] [30] . In contrast, a recent study showed that NELL1 can inhibit adipogenic differentiation of hADSCs by enhancing Hedgehog signaling [31] . PPARg is a nuclear hormone receptor that plays an important role in the differentiation of adipocytes by controlling the expression of adipocytespecific genes (i.e. LPL and AP2) [45, 46] . In addition, PPARg is critical for the maintenance of the balance between osteogenesis and adipogenesis [25, 27] . An in vitro study has revealed that BMP2 exerts its adipogenic effect by stimulating the transcriptional activity of PPARg and inducing its expression in C3H10T1/2 cells [28] . As expected, in this study, qPCR revealed that BMP2 could upregulate PPARg expression, but oil red O staining showed that lentiviral-mediated delivery of BMP2 does not significantly promote in vitro adipogenic differentiation of hADSCs. On the one hand, infection of hADSCs with LvBMP2 may not have generated functional BMP2. However, detection of cell proliferation, osteogenesis, and PPARg expression demonstrated that BMP2 was biologically active. On the other hand, high-dose BMP2 (300 ng/ ml) was found to exert an adipogenic effect in C3H10T1/2 cells in previous studies [28, 29] . Thus, the content of BMP2 after LvBMP2 infection might be insufficient to promote adipogenesis of hADSCs. BMP2 is a wellestablished osteogenic factor, and several studies showed that lentiviral-mediated BMP2 gene transfer is an effective and promising strategy for ex vivo gene therapy for bone regeneration [22] [23] [24] . However, our findings showed that LvBMP2 infection could not effectively inhibit adipogenic differentiation of hADSCs. In contrast, the results of qPCR assay for adipogenesis makers (PPARg and LPL) and oil red O staining indicated that the adipogenic differentiation of hADSCs was markedly suppressed after infection with LvNELL1. Of interest, the imaging and histological findings of a previous study showed that the bone was more robust after AdNELL1 infection than after AdBMP2 infection and that the bone formed after AdBMP2 infection contained a large amount of fatty marrow tissue [11] . The difference in the regulation of the balance between adipogenesis and osteogenesis by NELL1 and BMP2 may underlie the cause of this dissimilarity. In addition, ADSCs exhibited a superior capacity to undergo adipogenic differentiation both in vitro and in vivo compared with BMSCs [47] and therefore may not be good for the induction of high-quality bone formation, especially in load-bearing bone defects. Thus, LvNELL1 may be more suitable than LvBMP2 for ADSCs to induce bone regeneration. Taken together, our findings suggested that lentiviral-mediated NELL1 gene transfer could effectively inhibit adipogenic differentiation of hADSCs and might contribute to the production of high-quality bone, bone regeneration therapy, and even bone repair in some pathological conditions such as osteoporosis.
In conclusion, our study has proved the feasibility of lentivirus-mediated transfer of the NELL1 gene in hADSCs. LvNELL1-infected hADSCs could successfully express NELL1. LvNELL1 significantly increased osteogenesis of hADSCs in vitro, and the effect is comparable with that of LvBMP2. LvNELL1 could effectively inhibit the differentiation of hADSCs into adipocytes, whereas LvBMP2 did not significantly inhibit adipogenic differentiation of hADSCs. Our findings suggest that lentivirus-mediated transfer of the NELL1 gene into hADSCs may be a novel and promising strategy for ex vivo gene therapy to achieve effective and precise bone regeneration. Further study is needed to investigate the feasibility of this strategy in promoting bone formation in vivo.
